Agree Realty is an integrated real estate investment trust primarily focused on the ownership, acquisition, development and management of retail properties net leased to tenants. The company's assets are held by, and all of its operations are conducted through, directly or indirectly, Agree Limited Partnership, of which the company is the sole general partner and in which it holds a majority interest.

American Assets Trust is a self-administered real estate investment trust that owns, operates, acquires and develops retail, office, multifamily and mixed-use properties in Southern California, Northern California, Oregon, Washington, Texas and Hawaii. The company operates in four segments: Retail, which primarily include rental of retail space and other tenant services, including tenant reimbursements, parking and storage space rental; Office, which primarily include rental of office space and other tenant services; Multifamily, which include rental of apartments and other tenant services; and Mixed-use, which include rental of retail space and other tenant services.

Arvinas is a biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies to degrade disease-causing proteins. The company is developing its lead product candidates, ARV-110 and ARV-471, into Phase 1 clinical trials. The company has initiated a Phase 1 clinical trial for ARV-110 in men with metastatic castration-resistant prostate cancer. The company is developing ARV-471, a PROTAC targeted protein degrader targeting the estrogen receptor protein, or ER, for the treatment of women with locally advanced or metastatic ER positive / HER2 negative breast cancer.

BlackRock Capital Investment is a non-diversified closed-end management investment company. The company provides middle-market companies with financing solutions, including senior and junior secured, unsecured and subordinated debt securities and loans, and equity securities. The company's investment objective is to generate both income and capital appreciation through its debt and equity investments. The company invests primarily in middle-market companies and target investments throughout the capital structure. The company also invests throughout the capital structure, which include common and preferred equity, options and warrants, credit derivatives, high-yield bonds, distressed debt and other structured securities.

Camping World Holdings is a holding company. Through its subsidiaries, the company is a retailer of recreational vehicles (RVs) and RV-related products and services, and a retailer of outdoor lifestyle and active sports-related products and services. The company's segments include: consumer services and plans, which provides extended vehicle service contracts, emergency roadside assistance, property and casualty insurance programs, membership clubs, vehicle financing and refinancing, travel protection, and co-branded credit cards; dealership, which provides new vehicles and used vehicles; and retail, which includes: RV supply and maintenance products, and outdoor equipment and recreational products.

Central Valley Community Bancorp is a bank holding company. Through its subsidiary, Central Valley Community Bank (the Bank), the company provides a range of commercial banking services. The Bank conducts a commercial banking business, which includes accepting demand, savings and time deposits and making commercial, real estate and consumer loans. It also provides domestic and international wire transfer services and provides safe deposit boxes and other customary banking services. The Bank also provides Internet banking, which consists of inquiry, account status, bill paying, account transfers, and cash management. The Bank does not provide trust services or international banking services.

Century Bancorp is a bank holding company. Through its subsidiary, Century Bank and Trust Company, the company provides services to commercial enterprises, state and local governments and agencies, non-profit organizations and individuals. The company also provides securities brokerage services through a program called Investment Services at Century Bank, which is supported by LPL Financial, a third party securities brokerage business. The company grants single-family and multi-family residential loans, commercial and commercial real estate loans, municipal loans, and a variety of consumer loans. In addition, the company provides savings accounts, NOW accounts, demand deposits, time deposits and money market accounts.

Cidara Therapeutics is a biotechnology company focused on the discovery, development and commercialization of anti-infectives for the treatment and prevention of diseases. The company is developing a pipeline of product and development candidates, with a focus on fungal and infections. The company's primary product candidate is rezafungin acetate, an intravenous formulation of a echinocandin. Rezafungin is being developed as a once-weekly therapy for the first-line treatment and prevention of fungal infections. In addition, the company is using its Cloudbreak? platform to develop Antiviral Fc-Conjugates, for the prevention and treatment of influenza and other infections.

Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of sGC pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. The company's focus is enabling the full therapeutic potential of next-generation sGC stimulators. sGC stimulators are small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate, or cGMP. cGMP is a key second messenger that, when produced by sGC, regulates diverse and critical biological functions throughout the body including blood flow and vascular dynamics, inflammatory and fibrotic processes, metabolism and neuronal function.

Diversicare Healthcare Services provides post-acute care services to patients and residents including skilled nursing, ancillary health care services and assisted living. In addition, the company provides rehabilitative, nutritional, respiratory, and other ancillary services. The company's nursing centers provide skilled nursing health care services, including nutrition services, recreational therapy, social services, housekeeping and laundry services. This care includes individualized care plan development based on identified areas of risk and care needs and skilled interventions such as IV services. The company also provides for the delivery of ancillary medical services at the nursing centers it operates.

Golub Capital BDC is registered as an externally managed, closed-end, non-diversified management investment company. The company makes investments primarily in one stop (a loan that combines characteristics of first lien senior secured loans and second lien or subordinated loans) and other senior secured loans of middle-market companies that are, in most cases, sponsored by private equity firms. The company's investment objective is to generate existing income and capital appreciation by investing primarily in one stop and other senior secured loans of United States middle-market companies.

Hamilton Beach Brands Holding is a holding company. The company operates through its subsidiaries, Hamilton Beach Brands, Inc. (HBB) and The Kitchen Collection, LLC (KC), in the consumer, commercial and small appliances and specialty retail markets. HBB designs, markets and distributes a range of branded, small electric household and specialty housewares small appliances, including, but not limited to, blenders, can openers, coffeemakers, food processors, indoor electric grills, irons, mixers, slow cookers, toasters and toaster ovens. KC is a national specialty retailer of kitchenware. KC retail stores sell kitchenware from a number of name-brands, including Hamilton Beach? and Proctor Silex?.

Heartland Financial USA is a multi-bank holding company. The company conducts a community banking business through community banks (collectively, the Banks). The principal business of the company's Banks consists of making loans to and accepting deposits from businesses and individuals. The company's Banks provide commercial and retail banking in their communities. The company's lending and investment activities are funded primarily by core deposits. Deposit products include checking and other demand deposit accounts, Negotiable Order of Withdrawal accounts, savings accounts, money market accounts, certificates of deposit, individual retirement accounts, health savings accounts and other time deposits.

Integer Holdings is a medical device outsource manufacturing company. The company provides medical technologies and develops batteries for applications in energy, military, and environmental markets. The company's brands include Greatbatch Medical?, Lake Region Medical? and Electrochem?. The company organizes its business into two reportable segments, Medical and Non-Medical, and derive its sales from four principle product lines. The Medical segment includes the Cardio & Vascular, Cardiac & Neuromodulation and Advanced Surgical, Orthopedics & Portable Medical product lines and the Non-Medical segment is comprised of the Electrochem product line.

International Business Machines provides integrated solutions and products that utilize data, information technology, capability in industries and business processes. The company has five segments: Cloud and Cognitive Software, which provides a range of software offerings; Global Business Services, which provides consulting, systems integration, application management and business process outsourcing services; Global Technology Services, which provides project services, managed and outsourcing services, cloud-delivered services, and technical and IT support services; Systems, which provides technology and service; and Global Financing, which provides client financing, among others.

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The company employs research technologies such as antibody discovery technologies, structure-based drug design, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. The company's collaboration partners and licensees have programs in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.

Louisiana-Pacific is a provider of building solutions serving the new home construction, repair and remodeling and outdoor structures markets. The company has four segments: siding, which includes LP SmartSide? Strand and Fiber trim and siding, as well as LP Outdoor Building Solutions? products for outdoor buildings; oriented strand board (OSB), which manufactures and distributes OSB structural panel products; engineered wood products, which include LP SolidStart? I-Joist, Laminated Veneer Lumber, and other related products; and South America, which manufactures and distributes OSB structural panel and siding products in South America and certain export markets.

Matador Resources is an independent energy company engaged in the exploration, development, production and acquisition of oil and natural gas resources in the United States, with a focus on oil and natural gas shale and other unconventional plays. The company's operations are focused on the oil and liquids-rich portion of the Wolfcamp and Bone Spring plays in the Delaware Basin in Southeast New Mexico and West Texas. The company also operates in the Eagle Ford shale play in South Texas and the Haynesville shale and Cotton Valley plays in Northwest Louisiana. Also, the company conducts midstream operations, through its midstream joint venture, San Mateo Midstream, LLC together with San Mateo Midstream II, LLC.

Medpace Holdings is a holding company. Through its subsidiaries, the company is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The company provides a range of services supporting the clinical development process from Phase I to Phase IV. The company provides these services across a range of therapeutic areas. The company's line of clinical development services includes, but is not limited to, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, medical writing, data management, pharmacovigilance, and molecular and genetic testing.

Myriad Genetics is a precision medicine company acting as a trusted advisor to transform patient lives through molecular diagnostics. The company's molecular diagnostic tests include: myRisk? Hereditary Cancer for assessing the risks for hereditary cancers; BRACAnalysis? for assessing the risk of developing breast and ovarian cancer; riskScore? that improves the company's myRisk Hereditary Cancer test; GeneSight? to support psychotropic drug selection for depressed patients; Vectra?DA for assessing the disease activity of rheumatoid arthritis; and Prolaris? for assessing the aggressiveness of prostate cancer. The company also provides pharmaceutical and clinical services.

Net 1 UEPS Technologies provides financial technology, products and services. The company has developed and owns most of its payment technologies, and where possible, utilizes this technology to provide financial and services to its customers by including them into the formal financial system. The company's primary payment technology is called the Universal Electronic Payment System (UEPS), and its EMV interoperable derivative, UEPS/EMV, utilizes a form of distributed ledger technology, providing decentralized and biometrically secure smart cards that operate in real-time but both off-line and on-line. The company's financial inclusion products and services are delivered through its UEPS-based core banking system.

OFS Capital is an externally managed, closed-end, non-diversified management investment company. The company's investment objective is to provide its stockholders with both income and capital appreciation primarily through debt investments and, to a lesser extent, equity investments.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Peapack-Gladstone Financial is a bank holding company. Through its subsidiary, Peapack-Gladstone Bank, the company provides private banking services to businesses, non-profits and consumers. In addition to commercial lending activities, the company provides consumer banking services, including checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, and individual retirement accounts. The company also provides residential mortgages, home equity lines of credit and other second mortgage loans. Automated teller machines are available at various locations. Internet banking, including an online bill payment option and mobile phone banking, is available to clients.

Radius Health is a biopharmaceutical company focused on developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company's commercial product, TYMLOSTM (abaloparatide) injection is designed for the treatment of postmenopausal women with osteoporosis at high risk for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. The company is developing an abaloparatide transdermal patch for potential use in the treatment of postmenopausal women with osteoporosis. The company is also developing its Elacestrant, a selective estrogen receptor degrader, for potential use in the treatment of hormone receptor-positive breast cancer.

Spok Holdings provides a suite of unified clinical communication and collaboration solutions that include call center operations, clinical alerting and notifications, one-way and two-way wireless messaging services, mobile communications and public safety solutions. The company also develops, sells and supports enterprise-wide systems for hospitals and other organizations needing to automate, centralize and standardize mission clinical communications. These solutions are used for contact centers, clinical alerting and notification, mobile communications and messaging and for public safety notifications.

Superior Industries International is engaged in the design and manufacture of aluminum wheels for sale to original equipment manufacturers (OEMs) in North America and Europe and aftermarket distributors in Europe. The company's OEM aluminum wheels are primarily sold for factory installation on vehicle models manufactured by BMW (including Mini), Daimler AG Company (Mercedes-Benz, AMG, Smart), FCA, Ford, GM, Honda, Jaguar-Land Rover, Mazda, Nissan, PSA, Renault, Subaru, Suzuki, Toyota, VW Group (Volkswagen, Audi, SEAT, Skoda, Porsche, Bentley) and Volvo. The company also sells aluminum wheels to the European aftermarket under the brands ATS, RIAL, ALUTEC and ANZIO.

Synalloy is engaged in the following segments, the Metals segment and the Specialty Chemicals segment. The Metals segment manufactures welded pipe and tube, primarily from stainless steel, duplex, and nickel alloys; manufactures fiberglass and steel storage tanks; distributes hot finish, seamless, carbon steel pipe and tubing; and manufactures ornamental stainless steel tubing. The Specialty Chemicals segment manufactures lubricants, surfactants, defoamers, reaction intermediaries, and sulfated fats and oils, and provides chemical tolling manufacturing resources to global and regional companies and contracts with other chemical companies to manufacture certain pre-defined products.

TRACON Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of targeted therapeutics for cancer and wet age-related macular degeneration. The company is developing its primary product candidate, TRC105 (carotuximab), an endoglin antibody, for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor pathway, or in combination with inhibitors of the programmed cell death protein 1 pathway. The company's second clinical stage product oncology candidate is TRC102, a small molecule being developed for the treatment of lung cancer and mesothelioma.

Vertex Pharmaceuticals is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and developing research and development programs in other indications. The company's marketed products are TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (tezacaftor in combination with ivacaftor), ORKAMBI (lumacaftor in combination with ivacaftor) and KALYDECO (ivacaftor), which are approved to treat patients with CF who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene. The company is evaluating CTX001, a genetic therapy as a potential treatment for sickle cell disease and beta-thalassemia.

ViewRay designs, manufactures and markets the ViewRay MRIdian?. The MRIdian is a system that integrates radiation therapy with simultaneous magnetic resonance imaging (MRI). There are two generations of the MRIdian: the first generation MRIdian with Cobalt-60 based radiation beams and the second generation MRIdian Linac, with linear accelerator or linac based radiation beams. MRIdian integrates MRI technology, radiation delivery and the company's proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy and strike the target using real-time targeting throughout the treatment. The MRIdian system is sized to fit into standard radiation therapy vaults.

Virtu Financial is a holding company. Through its subsidiaries, the company is a financial firm. The company has two operating segments: Market Making, which principally consists of market making in the cash, futures, and options markets across global equities, options, fixed income, currencies and commodities; and Execution Services, which provides agency execution services and trading venues that provide transparent trading in global equities, ETFs, fixed income, currencies, and commodities to institutions, banks and broker dealers, as well as provides soft dollar and commission recapture programs.

Vishay Precision Group is a designer, manufacturer and marketer of sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages. The company provides precision products and solutions, engaging in the markets of stress, force, weight, pressure, and current measurements. Force Sensors, which includes a line of load cells and force measurement transducers that are provided as precision sensors for industrial and commercial use; and Weighing and Control Systems, which designs and manufactures systems comprised of load cells and instrumentation for weighing and force control/measurement for a variety of uses, including on-board weighing and overload monitor systems.

Xerox is a workplace technology company. The company's business areas are: Xerox Services, which offerings in this area are Intelligent Workplace Services and a range of Digital Services that utilize the company's software capabilities in Workflow Automation, Personalization and Communication Software, Content Management Solutions, and Digitization Services; Workplace Solutions, which is made up of two product groups, Entry and Mid-Range, which share common technology, manufacturing and product platforms; and Graphic Communications and Production Solutions, which are designed for customers in the graphic communications, in-plant and production print environments with high-volume printing requirements